Vitestro Device
Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device
April 30, 2024 07:00 ET | Vitestro
Vitestro lands $22M to ramp up commercialization efforts for robotic blood draw device
Vantage Market Research.png
Global Vein Illuminator Market to Reach USD 327.2 Million by 2028 - Rising Demand of Vein Illuminator from Hospitals to Boost Market - Exclusive Report by Vantage Market Research
January 31, 2022 06:33 ET | Vantage Market Research
WASHINGTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Vein Illuminator Market finds that mounting demand of Vein Illuminator from hospitals is...
Moffitt Cancer Center Advances Patient Standard of Care by Introducing Needleless Blood Draws
March 24, 2021 10:00 ET | Moffitt Cancer Center
TAMPA, Fla., March 24, 2021 (GLOBE NEWSWIRE) -- Moffitt Cancer Center has adopted a new needle-free method of blood collection for patients in treatment who often need to undergo repeated needle...
Holy Name Medical Center Launches One-Stick Hospitalization as New Inpatient Standard of Care
February 11, 2021 08:00 ET | Holy Name Medical Center
TEANECK, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Holy Name Medical Center today announced that it is the first hospital in New Jersey among a growing number of health systems nationwide to offer...
Velano Vascular Named Top Impact Company for 2021 by Real Leaders
January 13, 2021 09:00 ET | Velano Vascular
Velano recognized for pioneering a more humane standard of care for hospital patients; follows on heels of being named fastest growing medical device company in the U.S. and one of world’s most...
Velano Secures Additional Funding to Meet Commercial Demand for PIVO, Fueled by Industry Move to One-Stick Hospitalization
December 17, 2019 07:00 ET | Velano Vascular
- Latest funding caps year of groundbreaking milestones for transformative vascular access company; new capital will be used to meet rapidly growing hospital and patient demand - SAN FRANCISCO, Dec. ...
Velano Vascular Receives Frost & Sullivan’s 2019 North America Product Leadership Award for Needle-free Venous Access Technology
November 20, 2019 08:00 ET | Velano Vascular
SAN FRANCISCO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular today announced that it has been named the Frost & Sullivan 2019 North American Product...
Velano Primes for Growth with Funding from Intermountain Healthcare and Notable Individual Investors to Transform Blood Collection Globally
May 08, 2019 07:00 ET | Velano Vascular
SAN FRANCISCO, May 08, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular today announced that it has secured $10 million as the initial tranche of a growth financing to...
Velano Named One of Fast Company’s 2019 Top Ten Most Innovative Companies in Biotech for Pioneering Better Blood Draws
February 20, 2019 10:06 ET | Velano Vascular
SAN FRANCISCO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies...
Velano Adds to Leadership Team and Advisory Board to Accelerate Adoption of Novel Human-Centered Standard of Care for Inpatient Blood Draws 
December 05, 2018 08:00 ET | Velano Vascular
SAN FRANCISCO, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Vascular access technology innovator Velano Vascular continues to aggressively expand in pursuit of its mission to dramatically remake blood...